Стр. 336 - 2

449. The role of SOCS-3 in leptin signaling and leptin resistance / C. Bjorbaek [et
al.] // J Biol Chem. – 1999. – Vol. 274. – P. 3059-3065.
450. The role of the sympathetic nervous system in obesity-related hypertension / A.
A. da Silva [et al.] // Curr. Hypertens. Rep. – 2009. – Vol. 11, № 3. – P. 206 –
211.
451. The stomach is a source of leptin / A. Bado [et al.] // Nature. – 1998. – Vol.
394. – P. 790-793.
452. The underlying mechanisms for development of hypertension in the metabolic
syndrome / H. Yanai [et al.] // Nutr. J. – 2008. - № 7. – P. 10.
453. Third report of the National Cholesterol Education Program (NCEP) expert
panel on detection, evaluation, and treatment of high blood cholesterol in
adults (Adult Treatment Panel III). Final Report // Circulation. – 2003. –Vol.
106. –Р.3143–3421.
454. Thome A. Alexitimia and Acquired Immunne Deficiency Syndrome / A.
Thome // Psychother. Psychosom. – 1990. – № 54. – Р. 40-43.
455. Touyz R. M. Effects of and endothelin-1 on platelet aggregation and cytosolic
pH and free calcium concentrations in essential hypertension / R. M. Touyz, E.
L. Schiffrin // Hypertension. – 1993. – Vol. 22. – P. 853-862.
456. Touyz R. M. Intracellular Mg2+, Ca2+, Na+ and К+ in platelets and erythrocytes
of essential hypertension patients: relation to blood pressure/ R. M. Touyz, F.
J. Milne, S. G. Reinach // Clin. and Exp. Hypertens. – 1992. – Vol. 14, № 6. –
P. 1189–1209.
457. Trends in mortality from cardiovascular and cerebrovascular diseases in
Europe and other areas of the world / F. Levi [et al.] // Heart. — 2002. – Vol.
88. – P. 119—124.
458. Trends in the prevalence, awareness, treatment and control of hypertension: the
WHO MONICA Project / R. L. Antikainen[et al.] // Eur. J. Cardiovasc. Prev.
Rehabil. – 2006. – Vol. 13, № 1. – Р. 13-29.